ITMCTR2000004198
Recruiting
Phase 1
A multi-center, prospective clinical trial for KUSHEN Ningjiaos was inserted into rectum to reduce the rate of radiation proctitis in re-irradiation of patients with local recurrence of cervical cancer
Guangdong Provincial Hospital of Traditional Chinese Medicine (the Second Affiliated Hospital of Guangzhou University of traditional Chinese Medicine)0 sitesTBD
ConditionsRadiation proctitis
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Radiation proctitis
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine (the Second Affiliated Hospital of Guangzhou University of traditional Chinese Medicine)
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients who have received radical radiotherapy or hysterectomy plus adjuvant radiotherapy after pathological diagnosis of cervical cancer;
- •2\. Patients with local recurrence of cervical cancer 3 months after the end of treatment were confirmed by pathology and imaging;
- •3\. Patients who received external pelvic radiation therapy (EBRT) and intracavitary brachytherapy (BT) were treated with radiotherapy;
- •4\. Patients with chronic radiation proctitis before radiotherapy and the severity should be less than or equal to grade I.
- •5\. Patients with KPS score \>\= 60;
- •6\. Patients who voluntarily participated in the trial and signed informed consent in writing;
- •7\. Patients aged 18\-75 years.
Exclusion Criteria
- •1\. Patients with other malignant tumors before enrollment;
- •2\. Those patients whose first treatment after diagnosis of cervical cancer does not include radiotherapy;
- •3\. Patients with distant recurrence at the same time;
- •4\. Patients with serious organic diseases such as heart, lung, liver and kidney;
- •5\. Patients with severe radiation proctitis (acute grade \>\= 3 or chronic grade \= III) in the first radiotherapy.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Multicenter, prospective randomized trial on the use of prothrombin complex and fresh frozen plasma in patients with intracerebral hemorrhage related to vitamin K antagonists (VKA) - ICH-VKAIntracerebral hemorrhage (ICH) in patients related to vitamin K antagonistsMedDRA version: 14.1Level: LLTClassification code 10022754Term: Intracerebral hemorrhageSystem Organ Class: 10029205 - Nervous system disordersEUCTR2008-005653-37-DEniversityhospital of Heidelberg
Active, not recruiting
Phase 1
Acute treatment of stroke in patients reciving anticoagulant treatmentEUCTR2008-005653-37-DKniversityhospital of Heidelberg74
Completed
Not Applicable
Prospective, controlled, multicenter trial on the prognostic significance of video capsule endoscopy (Capsule Endoscopy) of the small intestine in ulcerative colitisK51Ulcerative colitisDRKS00009235CED Service GmbH128
Not yet recruiting
Phase 1
A randomized, Controlled, Multicenter Clinical Study Comparing the Efficacy and Safety of Saubude-9 pills in the treatment of Sa disease (cerebral infarction)Cerebral infarction recovery periodI69.300×003ITMCTR2200006153Inner Mongolia International Mongolian Medical Hospital
Recruiting
Not Applicable
Prospective, multicentre trial evaluating O-(2-[18F]-fluoroethyl)-L-tyrosine Positron Emission Tomography in Glioblastoma (FET-PET in Glioblastoma)FIG StudyCancerGlioblastomaCancer - BrainACTRN12619001735145Trans Tasman Radiation Oncology Group210